Cargando…
Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis
The aim of the present meta-analysis study was to evaluate the efficacy of low-dose aspirin, commenced at ≤16 weeks of gestation, in preventing preterm and term preeclampsia, as well as associated maternal and neonatal adverse events in women at risk of preeclampsia. The Embase, PubMed, Cochrane Cen...
Autores principales: | Cui, Yuechong, Zhu, Bin, Zheng, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920352/ https://www.ncbi.nlm.nih.gov/pubmed/29725376 http://dx.doi.org/10.3892/etm.2018.5972 |
Ejemplares similares
-
Aspirin for Prevention of Preeclampsia
por: Atallah, A., et al.
Publicado: (2017) -
The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta
por: Walsh, Scott W., et al.
Publicado: (2021) -
Low-Dose Aspirin for Preventing Birth of a Small-For-Gestational Age Neonate in a Subsequent Pregnancy
por: Hastie, Roxanne, et al.
Publicado: (2022) -
Low-dose aspirin in the prevention of preeclampsia in twin pregnancies: A real-world study
por: Zhou, Qiongjie, et al.
Publicado: (2023) -
Aspirin for Prevention of Preeclampsia in Lupus Pregnancy
por: Schramm, Amelie M., et al.
Publicado: (2014)